⌕
Bio-Techne · TECH · Nasdaq
Tenet 51 · Mixed
Compare
$72.79−0.01%At closeTenet 51 · Mixed
$72.79−0.01 (−0.01%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Bio-Techne (TECH) Stock

Bio-Techne (TECH) closed at $72.79 on Nov 16, 2026; its Tenet Score is 51 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$72.79
Nov 16, 2026
Market cap
$11.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
66.9×
price ÷ earnings
Dividend yield
0.44%
past year's regular dividends ÷ price
52-week range
43.20 – 72.88
low → high · as of close, Nov 13, 2026
Tenet Score
51/100
Mixed · 313 Healthcare peers

Industry: Drugs

Bio-Techne Corp scores 51/100. Mixed. Strongest on quality, value is the soft spot, trading at 67× earnings versus 313 Healthcare peers.

Tenet Score · vs sector

n=313
51/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
27
Quality
73
Health
53
Growth
52

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityBHealthCGrowthCMomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
5.3×
price to book value
P/S
9.3×
price to fiscal 2026 sales
ROE
8%
return on equity
Operating margin
20.7%
fiscal 2026, before interest and tax
Net margin
14.0%
of revenue kept
Current ratio
2.28
current assets to liabilities
Net debt / EBITDA
−0.4×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Prot…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 185 US ETFs · top wrappers by weightSee all ETFs holding TECH →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Bio-Techne in?

Bio-Techne is in the Healthcare sector and the Drugs industry.

What is Bio-Techne's Tenet Score?

Bio-Techne's Tenet Score is 51 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.